Skip to main content
Equibles
INSP logo

INSP · Inspire Medical Systems, Inc. · Analyst Estimates

Track INSP — free

Use INSP with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INSP.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$67.21 -0.89 (-1.31%) At close · Nov 2 Q3 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.97B
Shares
28.91M
Volume · Nov 2 1.08M Avg daily vol (3M) 781.19K

Analyst Estimates

Compare analyst forecasts for Inspire Medical Systems, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-27 18:05 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
1.17
1.25
1.34
14
1.25
1.25
1.25
0.90
0
0
1
2
Revenue
USD
Publication date not stated
840.10M
853.86M
861.90M
17
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
1.33
1.54
1.78
15
1.54
1.54
1.54
1.26
1
1
1
2
Revenue
USD
Publication date not stated
859.19M
887.18M
908.40M
17
 — — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.13
0.091
0.17
14
0.091
0.087
0.087
0.14
8
8
2
2
Revenue
USD
Publication date not stated
202.80M
204.31M
207.00M
17
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.79
0.91
1.06
14
0.91
0.91
0.91
0.90
4
4
6
6
Revenue
USD
Publication date not stated
230.50M
244.37M
251.60M
16
 — — — — — — — —
Key facts CIK 1609550 CUSIP 457730109 13F (30d) 76 filings 74 filers Visit website Investor relations